Metzger Michael A 4
4 · Syndax Pharmaceuticals Inc · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Metzger Michael A
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock options (Right to buy)
2025-03-14+6,074→ 0 totalExercise: $7.20Exp: 2025-06-01→ Common Stock (6,074 underlying) - Exercise/Conversion
Common Stock
2025-03-14$7.20/sh+6,074$43,733→ 306,195 total
Footnotes (1)
- [F1]This option is fully vested.